Therma Bright (THRM) AI Stock Analysis

• Market Cap: C$3.77M
• Dividend Yield: N/A
• Average Volume (3M): 50.06K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.75
• Revenue Growth: 207.90%
• EPS Growth: -23.09%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): >-0.01
• Shares Outstanding: 58,002,876
• 10 Day Avg. Volume: 51,225
• 30 Day Avg. Volume: 50,057
• PEG Ratio: >-0.01
• Price to Book (P/B): -2.51
• Price to Sales (P/S): 48.92
• P/FCF Ratio: -26.80
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: C$0.06 ▲(6.67% Upside)
• Action: Reiterated Date: 04/08/26
• Date: Action: Reiterated 04/08/26

The score is held down primarily by weak financial performance (ongoing large losses, negative equity, and continued cash burn). Technical indicators provide a modest offset with improving momentum above shorter-term moving averages, while valuation is constrained by negative earnings and no dividend support.

Positive Factors

Low reported debt

Very low reported debt materially reduces near-term leverage risk and interest obligations, giving management breathing room to execute restructuring or commercialization moves. That durable low-leverage profile improves flexibility to raise capital or negotiate terms without heavy debt service pressure.

Negative Factors

Negative shareholders' equity

Meaningfully negative equity reflects accumulated losses and a weakened balance sheet, limiting financial flexibility and making new equity raises or credit access more dilutive or costly. Over the medium term, negative equity constrains strategic options and heightens solvency scrutiny from counterparties.

Therma Bright Business Overview & Revenue Model

Company Description

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an anti...

Read more

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an anti...

How the Company Makes Money

Revenue is generated primarily through the sale and distribution of the company’s healthcare and medical device products (including any diagnostic test products it commercializes) to customers through applicable sales channels (e.g., direct sales ...

Read more

Revenue is generated primarily through the sale and distribution of the company’s healthcare and medical device products (including any diagnostic test products it commercializes) to customers through applicable sales channels (e.g., direct sales ...

Therma Bright Financial Statement Overview

Breakdown	TTM	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021
Income Statement
Total Revenue	67.45K	80.27K	26.07K	23.90K	139.43K	3.88K
Gross Profit	14.91K	-36.93K	25.46K	23.90K	63.48K	3.88K
EBITDA	-3.91M	-4.25M	-2.34M	-3.68M	-5.83M	-8.55M
Net Income	-3.97M	-4.34M	-2.45M	-3.77M	-5.88M	-8.61M
Balance Sheet
Total Assets	246.60K	248.69K	3.19M	2.21M	4.00M	2.24M
Cash, Cash Equivalents and Short-Term Investments	36.19K	38.07K	1.10K	182.24K	3.08M	1.78M
Total Debt	40.00K	40.00K	65.39K	90.39K	110.55K	40.00K
Total Liabilities	2.08M	1.81M	1.87M	2.16M	1.25M	927.12K
Stockholders Equity	-1.83M	-1.57M	1.32M	44.79K	2.75M	1.32M
Cash Flow
Free Cash Flow	-126.38K	-146.53K	-1.01M	-2.44M	-3.80M	-3.16M
Operating Cash Flow	-164.53K	-146.53K	-1.01M	-2.17M	-3.80M	-2.86M
Investing Cash Flow	0.00	0.00	-138.26K	-691.08K	-204.93K	-300.00K
Financing Cash Flow	168.43K	146.90K	966.40K	-33.60K	5.31M	3.87M

Therma Bright Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.06
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:THRM, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.06, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.35 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:THRM.

Therma Bright Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
THRM	47 Neutral	C$3.77M	-3.15	-9999.00%	―	207.90%	-23.09%
PRN	46 Neutral	C$329.55M	-5.47	-85.73%	―	72.03%	-1.47%
TLT	46 Neutral	C$65.55M	-11.76	-269.41%	―	1.46%	6.91%
PINK	42 Neutral	C$41.62M	-1.50	-220.14%	―	209.29%	35.38%
ASTI	42 Neutral	C$275.99K	0.24	4.41%	―	-57.16%	2.93%

Therma Bright Corporate Events